|Type||Public (LSE: VCT)|
|Headquarters||Victrex Technology Centre, Hillhouse International, Thornton Cleveleys, Lancashire, FY5 4QD, England, UK|
|Key people||Anita Frew
|Revenue||£221.9 million (2013)|
|Operating income||£94.0 million (2013)|
|Net income||£72.9 million (2013)|
The company was established in 1993 by way of a management buyout of the PEEK polymer business of Imperial Chemical Industries plc. It was first listed on the London Stock Exchange in 1995. Based in Cleveleys near Blackpool in Lancashire Victrex has historically invested heavily to increase its capacity, most recently investing £90 million to increase production capacity by around 70%. By 2015 the production capacity of its polymer will be at 7,000 MT per annum (current capacity of 4,250 MT per annum).
- Victrex Polymer Solutions (VPS) - that focuses on transport, industrial and the electronics markets
- Invibio Biomaterial Solutions (Invibio) - that focuses on providing specialist solutions for medical device manufacturers.